Reckitt Benckiser Group’s Mead Johnson Nutrition (MJN) is issuing a voluntary recall of certain batches of Nutramigen Powder in the United States. The recall is due to a potential contamination with Cronobacter sakazakii bacteria, which was found in product samples taken outside of the country. The Food and Drug Administration (FDA) announced this recall on Sunday.
Nutramigen Powder is a specialized infant formula designed for the dietary management of Cows Milk Allergy (CMA). The affected product comes in 12.6- and 19.8-ounce cans. Despite extensive testing conducted by MJN, the formula tested negative for the bacteria, according to the FDA.
The recalled Nutramigen containers were manufactured in June 2023 and primarily distributed in June, July, and August. However, the FDA believes that most, if not all, of the products have already been consumed due to limited availability. Fortunately, there have been no reports of illnesses or adverse events associated with the recalled batches.
All the recalled products have a “Use By Date” of “1 Jan 2025.” Reckitt Benckiser advises customers to dispose of any products belonging to the recalled batches. It is important to note that no other Nutramigen batches or Reckitt products distributed in the United States are affected by this recall.
Cronobacter sakazakii bacteria can cause severe and life-threatening infections, including meningitis. Infections may also lead to bowel damage and can spread through the bloodstream to other parts of the body.
To ensure consumer safety, it is crucial to follow the recall instructions provided by Reckitt Benckiser and dispose of any affected Nutramigen Powder cans. Regularly checking for product recalls and taking appropriate actions is essential for maintaining the well-being of infants and children.
